Transradial Access Market Overview:
The Transradial Access Devices Market is projected to be valued at USD 1.52 Billion in 2017 and is expected to grow at a CAGR of 7.5% to reach to USD 2.18 Billion by 2022.
Becton, Dickinson and Company (US) is the leading player in the global transradial access devices market. The company develops, manufactures, and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products. BD’s products are used by healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry. The company operates through two business segments - BD Medical and BD Life Sciences. The BD Medical segment offers products through four business units, namely, Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, and Pharmaceutical Systems. The Medication and Procedural Solutions business unit of the company offers vascular access devices, including intravenous catheters for medication delivery including safety-engineered and auto-disable devices. The company operates through a network of offices in more than 50 countries across North America, Europe, Asia Pacific, Eastern Europe, Latin America and the Middle East and Africa.
The company focuses on expanding its market presence by adopting growth strategies, such as acquisitions, and product launches. For instance, BD acquired two companies (C R Bard and CareFusion) in last 2 years. The company also focuses on enhancing its R&D capabilities, BD invested USD 774 million in R&D activities in 2017. Thus, with its robust product portfolio and efforts to develop innovative products by investing in R&D, the company is likely to maintain its leadership position in this market.
Terumo Corporation (Japan) develops and manufactures medical devices, supplies, and accessories. The company offers its products through three divisions, namely, Cardiac and Vascular, General Hospital, and Blood Management. The Cardiac and Vascular division specializes in two therapeutic areas – endovascular intervention and cardiovascular surgery. The company offers vascular access devices through its endovascular intervention therapeutic area. Terumo has a geographic presence in over 160 countries, with 82 sales offices and 24 production facilities across the globe. As of March 2017, the company had about 30 production sites in key geographies such as the US, the UK, Belgium, Vietnam, Philippines, China, India, Japan, and Costa Rica.
Request For Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=14566259
Top-down and bottom-up approaches were used to validate the size of the global transradial access market and estimate the size of other dependent submarkets. Various secondary sources such as World Health Organization (WHO), Central Intelligence Agency (CIA), Centers for Disease Control and Prevention (CDC), European Renal Care Providers Association (ERCPA), Society for Cardiovascular Angiography and Interventions (SCAI), American Heart Association (AHA), Canadian Association of Interventional Cardiology (CAIC), Asian Pacific Society of Interventional Cardiology (APSIC), American College of Cardiology, directories, industry journals, databases, and annual reports of companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
Sheaths & Sheath Introducers
Fluid & Nutrition Administration
Diagnostics & Testing
By End User
Clinics & Ambulatory Care Centers
Other End Users
Detailed Information: https://www.marketsandmarkets.com/Market-Reports/transradial-access-market-14566259.html
Becton, Dickinson and Company (US) and Terumo Corporation (Japan) dominated the transradial access devices market in 2016. The other players in the market are Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441